Aviance Capital Partners LLC Acquires 63 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Aviance Capital Partners LLC lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,478 shares of the medical equipment provider’s stock after acquiring an additional 63 shares during the period. Aviance Capital Partners LLC’s holdings in Intuitive Surgical were worth $771,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in ISRG. Berbice Capital Management LLC bought a new stake in Intuitive Surgical in the fourth quarter worth about $26,000. BankPlus Trust Department bought a new stake in Intuitive Surgical in the fourth quarter worth about $28,000. Kohmann Bosshard Financial Services LLC bought a new stake in Intuitive Surgical in the fourth quarter worth about $31,000. MidAtlantic Capital Management Inc. bought a new stake in Intuitive Surgical in the third quarter worth about $33,000. Finally, Decker Retirement Planning Inc. bought a new stake in Intuitive Surgical in the fourth quarter worth about $36,000. Institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, SVP Mark Brosius sold 489 shares of Intuitive Surgical stock in a transaction on Friday, March 7th. The shares were sold at an average price of $533.18, for a total value of $260,725.02. Following the transaction, the senior vice president now directly owns 2,091 shares of the company’s stock, valued at approximately $1,114,879.38. The trade was a 18.95 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 270 shares of Intuitive Surgical stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,730,093.55. This represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 13,579 shares of company stock valued at $7,756,844. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Trading Down 3.8 %

NASDAQ ISRG opened at $518.26 on Friday. The firm’s fifty day simple moving average is $571.36 and its two-hundred day simple moving average is $531.20. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The firm has a market capitalization of $184.59 billion, a P/E ratio of 80.85, a P/E/G ratio of 5.85 and a beta of 1.43.

Wall Street Analysts Forecast Growth

ISRG has been the topic of a number of research reports. JPMorgan Chase & Co. raised their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. CICC Research initiated coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They set a “neutral” rating and a $550.00 target price on the stock. Royal Bank of Canada raised their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. Finally, Jefferies Financial Group raised their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.